• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.71% Nasdaq Up1.29%

    INSYS Therapeutics, Inc. (INSY)

    -NasdaqGM
    60.99 Up 1.27(2.13%) 2:09PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014
    Total Revenue 70,770   66,512   58,281   55,696  
    Cost of Revenue6,375  5,860  5,390  6,555  
    Gross Profit 64,395   60,652   52,891   49,141  
    Operating Expenses
    Research Development10,602  12,921  7,018  9,189  
    Selling General and Administrative42,162  31,585  25,851  24,766  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss 11,631   16,146   20,022   15,186  
    Income from Continuing Operations
    Total Other Income/Expenses Net125  65  43  26  
    Earnings Before Interest And Taxes11,756  16,211  20,065  15,212  
    Interest Expense -   -   -   -  
    Income Before Tax11,756  16,211  20,065  15,212  
    Income Tax Expense3,733  6,862  8,560  5,747  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops8,023  9,349  11,505  9,465  
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income 8,023   9,349   11,505   9,465  
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares 8,023   9,349   11,505   9,465  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.